Ndnf Interneuron Excitability Is Spared in a Mouse Model of Dravet Syndrome

被引:0
|
作者
Liebergall, Sophie R. [1 ,2 ,3 ]
Goldberg, Ethan M. [1 ,2 ,4 ,5 ,6 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Med Scientist Training Program, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, Neurol, Philadelphia, PA 19104 USA
[5] Childrens Hosp Philadelphia, Epilepsy Neurogenet Initiat, Philadelphia, PA 19104 USA
[6] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA
来源
JOURNAL OF NEUROSCIENCE | 2024年 / 44卷 / 17期
基金
美国国家卫生研究院;
关键词
Dravet syndrome; interneurons; Nav1.1; Ndnf; neurogliaform; SCN1A; SEVERE MYOCLONIC EPILEPSY; NEUROPEPTIDE-Y; INHIBITORY INTERNEURONS; GABAERGIC INTERNEURONS; NEUROGLIAFORM CELLS; PYRAMIDAL NEURONS; SODIUM; SEIZURES; CIRCUITS; ORGANIZATION;
D O I
10.1523/JNEUROSCI.1977-23.2024
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dravet syndrome (DS) is a neurodevelopmental disorder characterized by epilepsy, developmental delay/intellectual disability, and features of autism spectrum disorder, caused by heterozygous loss-of-function variants in SCN1A encoding the voltage-gated sodium channel alpha subunit Nav1.1. The dominant model of DS pathogenesis is the "interneuron hypothesis," whereby GABAergic interneurons (INs) express and preferentially rely on Nav1.1-containing sodium channels for action potential (AP) generation. This has been shown for three of the major subclasses of cerebral cortex GABAergic INs: those expressing parvalbumin (PV), somatostatin, and vasoactive intestinal peptide. Here, we define the function of a fourth major subclass of INs expressing neuron-derived neurotrophic factor (Ndnf) in male and female DS (Scn1a+/-) mice. Patch-clamp electrophysiological recordings of Ndnf-INs in brain slices from Scn1a+/& acirc; mice and WT controls reveal normal intrinsic membrane properties, properties of AP generation and repetitive firing, and synaptic transmission across development. Immunohistochemistry shows that Nav1.1 is strongly expressed at the axon initial segment (AIS) of PV-expressing INs but is absent at the Ndnf-IN AIS. In vivo two-photon calcium imaging demonstrates that Ndnf-INs in Scn1a+/& acirc; mice are recruited similarly to WT controls during arousal. These results suggest that Ndnf-INs are the only major IN subclass that does not prominently rely on Nav1.1 for AP generation and thus retain their excitability in DS. The discovery of a major IN subclass with preserved function in the Scn1a+/& acirc; mouse model adds further complexity to the "interneuron hypothesis" and highlights the importance of considering cell-type heterogeneity when investigating mechanisms underlying neurodevelopmental disorders.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Transcranial static magnetic stimulation reduces seizures in a mouse model of Dravet syndrome
    Rivadulla, C.
    Pardo-Vazquez, J. L.
    de Labra, C.
    Aguilar, J.
    Suarez, E.
    Paz, C.
    Alvarez-Doladog, M.
    Cudeiroa, J.
    EXPERIMENTAL NEUROLOGY, 2023, 370
  • [42] Efficacy of stiripentol in hyperthermia-induced seizures in a mouse model of Dravet syndrome
    Cao, Dezhi
    Ohtani, Hideyuki
    Ogiwara, Ikuo
    Ohtani, Sanae
    Takahashi, Yukitoshi
    Yamakawa, Kazuhiro
    Inoue, Yushi
    EPILEPSIA, 2012, 53 (07) : 1140 - 1145
  • [43] Adolescent behavioral abnormalities in a Scn1a+/- mouse model of Dravet syndrome
    Bahceci, Dilara
    Anderson, Lyndsey Leigh
    Brown, Cassandra Veronica Occelli Hanbury
    Zhou, Cilla
    Arnold, Jonathon Carl
    EPILEPSY & BEHAVIOR, 2020, 103
  • [44] FENFLURAMINE EXHIBITS DISEASE-MODIFYING EFFECTS IN A MOUSE MODEL OF DRAVET SYNDROME
    Reeder, Thaddeus
    Cha, John
    Filatov, Gregory
    Smith, Steve
    Wong, Darren
    Gammaitoni, Arnold
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [45] Protective effects of medium chain triglyceride diet in a mouse model of Dravet syndrome
    Jancovski, Nikola
    Baldwin, Tomas
    Orford, Michael
    Li, Melody
    Jones, Gabriel Davis
    Burbano, Lisseth Estefania
    Rutherford, Tricia
    Reid, Christopher
    Heales, Simon
    Eaton, Simon
    Petrou, Steven
    EPILEPSIA, 2021, 62 (12) : 3131 - 3142
  • [46] Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome
    Cha, John
    Filatov, Gregory
    Smith, Steven J.
    Gammaitoni, Arnold R.
    Lothe, Amelie
    Reeder, Thadd
    EPILEPSIA OPEN, 2024, 9 (01) : 300 - 313
  • [47] Chronic partial TrkB activation reduces seizures and mortality in a mouse model of Dravet syndrome
    Gu, Feng
    Parada, Isabel
    Yang, Tao
    Longo, Frank M.
    Prince, David A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (07)
  • [48] Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome
    Goff, Kevin M.
    Goldberg, Ethan M.
    ELIFE, 2019, 8
  • [49] Retinal Tissue Shows Glial Changes in a Dravet Syndrome Knock-in Mouse Model
    Salazar, Juan J.
    Satriano, Andrea
    Matamoros, Jose A.
    Fernandez-Albarral, Jose A.
    Salobrar-Garcia, Elena
    Lopez-Cuenca, Ines
    de Hoz, Rosa
    Sanchez-Puebla, Lidia
    Ramirez, Jose M.
    Alonso, Cristina
    Satta, Valentina
    Hernandez-Fisac, Ines
    Sagredo, Onintza
    Ramirez, Ana I.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [50] Defects of Oligodendrocyte Migration in the Scn1b-/- Mouse Model of Dravet Syndrome
    Clemons, Krisyah
    O'Malley, Heather A.
    Isom, Lori L.
    FASEB JOURNAL, 2019, 33